Angel round financing of over 10 million RMB has been finalized! Shenzhen Shenyi Technology Co., Ltd. integrates AI with BCI to make brain-computer intelligence accessible and affordable for the general public.

This round of financing will be mainly used for the R&D of core brain-computer interface technologies, mass production of consumer-grade products and overseas market expansion, as well as clinical verification and registration transformation of medical-grade products such as auxiliary diagnosis of depression and neuromodulation.

Shenyi Technology was founded in May 2025, focusing on the interdisciplinary innovation of AI + Brain Science. Centering on sleep disorders, depression and a variety of brain diseases, it develops brain function monitoring and intervention products based on artificial intelligence, non-invasive brain-computer interface and neuromodulation technologies.

▲ The cross-integration of AI and brain science is opening up new imaginative space for brain health management

01  "Serious Medical Care + Consumer Health": Two-Line Collaborative Development Path

Since its inception, Shenyi Technology has established the two-line collaborative development path of "Serious Medical Care + Consumer Health".

On the one hand, focusing on clinical needs such as sleep disorders and depression, it continues to deploy auxiliary diagnosis based on EEG signals, as well as precise neuromodulation technologies including electrical stimulation, temporal interference stimulation and combined acoustoelectric stimulation, to build a technical moat.

On the other hand, through wearable brain-computer interface products, it lowers the threshold for brain function monitoring and intervention to enter daily life; relying on the rapid large-scale application of consumer-grade products, it continuously accumulates large-scale real-world EEG and multi-modal data, and feeds back algorithm training, personalized model optimization and product iteration, forming a data flywheel of "user growth - data accumulation - algorithm improvement - experience optimization".

02  From Brain Function Monitoring to "Monitoring + Intervention"

Medical End: Build a Closed-Loop for Non-Invasive and Precise Neuromodulation Diagnosis and Treatment

▲ Focus Precisely on Neuromodulation

At the medical end, Shenyi Technology focuses on non-invasive, precise and deep brain neuromodulation, and builds a diagnosis and treatment closed loop from objective EEG assessment, personalized scheme decision-making to precise stimulation intervention for neuropsychiatric diseases such as sleep disorders and depression.

The company takes the closed-loop temporal interference electrical stimulation (TI) equipment as its first medical product, which not only realizes non-invasive precise stimulation of deep brain regions, but also dynamically optimizes the stimulation scheme through real-time feedback of multi-modal monitoring. According to the team, this product is also the first domestically developed closed-loop TI neuromodulation equipment for industrialization, which is different from most of the current technical routes dominated by one-way stimulation.

On this basis, Shenyi Technology also focuses on the layout of multi-modal combined acoustoelectric stimulation technology, exploring a neuromodulation scheme with higher precision and more personalized capability under the coordination of focused ultrasound and electrical stimulation. According to the team, Shenyi Technology is also the first domestic team that systematically deploys the industrialization of multi-modal combined acoustoelectric stimulation, and is gradually building a precise neuromodulation technology platform covering different targets, different depths and different disease stages.

Consumer End: Let Brain-Computer Interface Enter Daily Life "Unconsciously"

▲ Wearable brain-computer interface products integrate sleep and emotion management into daily life

At the consumer end, Shenyi Technology takes wearable brain-computer interface products as the entry point, combined with artificial intelligence algorithms to continuously analyze users' brain states related to sleep, emotion, etc., and further explore adaptive intervention based on individual brain states.

Focusing on the popular application of brain-computer interfaces, the company is continuously promoting miniaturization of hardware, intelligentization of algorithms and imperceptibility of use: by minimizing the volume of the EEG acquisition module, reducing power consumption and wearing burden, and at the same time using AI to improve the capabilities of EEG signal processing, brain state recognition and personalized analysis in complex environments, so that brain-computer interfaces can gradually enter the scenarios of sleep, emotion and daily brain health management.

Focusing on the brain health management needs of healthy people and the diagnosis and treatment needs of patients with different degrees of brain diseases, Shenyi Technology will gradually establish a hierarchical product system covering daily brain health management, home intervention for mild patients, in-hospital treatment for moderate and severe patients and long-term out-of-hospital management, promoting the capabilities of brain function monitoring and precise intervention to extend further from hospitals to families and daily life scenarios.

03  Joint Support from Market-oriented Capital and National Industrial Platform

The lead investor of this round is Shenzhen Guangming Lihe Science City Seed Venture Capital Fund Partnership (Limited Partnership) (hereinafter referred to as "Guangming Lihe Fund"), which is under Lihe Venture Capital. Lihe Venture Capital has long focused on early-stage scientific and technological innovation, adheres to the principle of "investing in early-stage projects, small enterprises and hard-core technologies", and focuses on the layout of technology enterprises with core technical barriers and industrialization potential. Guangming Lihe Fund is funded by Shenzhen Angel Mother Fund, Guangming District Guidance Fund, Lihe Technology Innovation and other parties.

Brain-computer interface is in the stage of accelerating evolution from cutting-edge technology verification to large-scale industrial implementation. Shenyi Technology has built a relatively complete technical system around EEG acquisition, AI algorithms, precise neuromodulation and engineering, and through the two-line layout of "serious medical care + consumer health", it has formed a development path that takes into account short-term commercial verification and long-term technology, clinical and regulatory barrier construction, with both technical depth, product implementation capability and industrialization potential.

—— Lihe Venture Capital

The follow-on investor of this round, Dongguan Biotech, focuses on cutting-edge fields such as biomedicine, medical devices and life health.

Neuropsychiatric diseases such as depression have significant long-term and hierarchical diagnosis and treatment needs. Shenyi Technology is gradually building a hierarchical product system covering patients with mild to moderate and severe depression around objective EEG assessment and precise neuromodulation, and promoting the extension of brain function monitoring and intervention capabilities from in-hospital to home, which has clear clinical value and large-scale application space.

—— Dongguan Biotech

In addition to the investment institutions in this round, one of the founding shareholders of Shenyi Technology is Shenzhen National Research Institute of High Performance Medical Devices Co., Ltd., which is the operating entity of the National Innovation Center for High Performance Medical Devices. This center is the first national-level manufacturing innovation center in Shenzhen, led and established by scientific research institutions, universities and leading medical device enterprises such as Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Mindray Medical, United Imaging, LifeTech, and Harbin Institute of Technology, which has long promoted the R&D and industrial transformation of key common technologies for high-performance medical devices.

Brain-computer interface is a cutting-edge direction of deep cross-integration of artificial intelligence, neuroscience and high-end medical devices. Shenyi Technology continues to promote productization around EEG, AI, precise neuromodulation and multi-modal diagnosis and treatment technologies, which is highly consistent with the direction of the innovation center to promote the engineering and industrialization of cutting-edge medical technologies.

—— National Innovation Center for High Performance Medical Devices

04  Make Brain-Computer Interface a Technology Truly Accessible to the Public

Gu Xiangkun, the founder of Shenyi Technology, said that the company will promote the deep integration of artificial intelligence and brain-computer interface technology for a long time, so that brain-computer interface is no longer just a cutting-edge technology in the laboratory, or equipment that only a few patients and professional institutions can use, but gradually becomes a brain health technology that the public can access and use for a long time.

AI is becoming an important force to promote the popularization of brain-computer interfaces. We hope to continuously promote the miniaturization of hardware, intelligentization of algorithms and imperceptibility of use, continuously lower the threshold for using brain-computer interfaces, make the perception, understanding and intervention of brain functions more precise, natural and popular, and let brain-computer interfaces truly move from laboratories to hospitals, and then from hospitals to families and the daily life of the public.

—— Gu Xiangkun, Founder of Shenyi Technology

05  Integration of Industry, University and Research to Accelerate Industrial Transformation

The core team of Shenyi Technology has a compound background in artificial intelligence, brain science, high-end medical devices, neuromodulation, software and hardware R&D, etc. The core members come from well-known enterprises such as United Imaging, Mindray, ByteDance, Tencent. Relying on the industry-university-research collaborative system composed of academicians of the Chinese Academy of Sciences, clinical experts from top three hospitals and senior R&D personnel of brain-computer interfaces, the company has formed core capabilities covering algorithms, hardware, clinical transformation and engineering, and is currently cooperating with industrial chains, scientific research and clinical institutions to accelerate the industrial implementation of serious medical products and consumer health.

After completing this round of financing, Shenyi Technology will further increase investment in the core technology direction of two-way brain-computer interface, and promote product marketization and global brand building. In the future, Shenyi Technology will continue to expand the innovation boundary in the fields of neuromodulation and cognitive health, promote the transformation of brain science achievements from laboratories to clinical and public applications, and serve the needs of hundreds of millions of users around the world in brain health management such as neurological health and emotional rehabilitation with brain-computer interface technology.